WhiteLab Genomics Email Format

Biotechnology ResearchÎle-de-france, France51-200 Employees

WhiteLab Genomics is a mid-sized biotechnology research company based in Paris, Île-de-France, with offices in Boston and Montréal, focused on applying artificial intelligence to genomic medicine. Founded in 2019, it operates at the intersection of AI, computational biology, and structural biology to speed discovery and preclinical development. Its core offering is an AI-driven platform that enables the rational design and optimization of delivery systems for gene therapies, including viral and non-viral vectors as well as RNA and DNA payloads; the company collaborates with industry partners and academic institutions to advance therapeutic platforms.

It serves a diverse set of partners across oncology, neurology, ophthalmology, auditory disorders, and rare diseases, supporting work from discovery through preclinical stages and aiming to design safer, more effective therapies. In 2024, Debiopharm Group announced a partnership with WhiteLab Genomics to advance research in cancer and infectious diseases.

Sign up for free to view info

Company overview Employee directory